News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Oncology-focused Progenics Pharmaceuticals has selected CMO Gallus BioPharmaceuticals to manufacture the anti-prostate specific membrane antigen (PSMA) monoclonal antibody used in Progenics’ PSMA ADC product candidate.
Ampio Biopharmaceuticals will delay the release of Ampion trial data after discovering the drug was damaged by temperature fluctuations during shipment.
Between 70-80% of ADC (antibody drug conjugate) manufacturing is performed by CMOs, according to a new report.
Correction
GE Healthcare has said it plans to relocate operations in New Jersey to its new Massachusetts life sciences headquarters.
Concerns passengers on a flight from Paris to Montpellier had the Ebola virus have proved to be false according to reports in the French media.